Literature DB >> 18671789

Risk factors for mortality and morbidity related to radical cystectomy.

Peter J Boström1, Jyrki Kössi, Matti Laato, Martti Nurmi.   

Abstract

OBJECTIVES: To evaluate the risk factors for mortality and morbidity related to radical cystectomy (RC) in a medium-sized academic centre, and to analyse the rate and trends of perioperative morbidity and mortality, as although complications related RC to are lower in modern than historic series, RC is still associated with marked risks. PATIENTS AND METHODS: The study included 258 patients undergoing RC for bladder cancer in Turku University Hospital in 1986-2005. Basic patient characteristics and in-hospital, early (from hospital discharge to 3 months) and combined morbidity and mortality were analysed. Risk analysis included 16 risk factors for complications. Trends were analysed by comparing the two study decades (1986-1995 vs 1996-2005).
RESULTS: The total complication rate was 34%, with minor and major complications in 26%, and 11% of patients, respectively. There were no significant changes in total morbidity, but the number of myocardial infarctions and atrial fibrillations decreased significantly (P = 0.045). Operative mortality was 2.7%, with an insignificant decrease (4.2% to 0.9%, P = 0.11) over time. Salvage RC, high American Society of Anesthesiologists (ASA) score (> or = 3), extensive blood loss (>3 L), a high number of transfusions (five or more), several comorbidities (two or more), age (> or = 65 vs <65 years), and extravesical tumours were significant risk factors for major complications. An ASA score of > or = 3 and five or more transfusions were the only factors associated with mortality. A high ASA score (odds ration 3.25, 95% confidence interval 1.08-9.74) and high number of transfusions (2.74, 1.05-7.15) were independent risk factors for major complications.
CONCLUSION: Although RC is associated with acceptable morbidity, attention should be given to risk factors identified at the time of patient selection, and to meticulous haemostasis at the time of surgery. A predictable outcome comparable to that in high-volume centres is also possible in a medium-sized hospital.

Entities:  

Mesh:

Year:  2008        PMID: 18671789     DOI: 10.1111/j.1464-410X.2008.07889.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  28 in total

1.  Alvimopan usage increasing following radical cystectomy.

Authors:  Joshua D Belle; Aydin Pooli; Dimitry Oleynikov; Christopher M Deibert
Journal:  World J Urol       Date:  2018-09-08       Impact factor: 4.226

2.  Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?

Authors:  Pranav Sharma; Kamran Zargar-Shoshtari; Michael A Poch; Julio M Pow-Sang; Wade J Sexton; Philippe E Spiess; Scott M Gilbert
Journal:  World J Urol       Date:  2016-08-05       Impact factor: 4.226

3.  A meta-analysis of the predictive accuracy of postoperative mortality using the American Society of Anesthesiologists' physical status classification system.

Authors:  Chieh Yang Koo; Joseph A Hyder; Jonathan P Wanderer; Matthias Eikermann; Satya Krishna Ramachandran
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

4.  Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database.

Authors:  Giorgio Gandaglia; Briony Varda; Akshay Sood; Daniel Pucheril; Ramdev Konijeti; Jesse D Sammon; Shyam Sukumar; Mani Menon; Maxine Sun; Steven L Chang; Francesco Montorsi; Adam S Kibel; Quoc-Dien Trinh
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

5.  Enhanced recovery for non-colorectal surgery.

Authors:  Gianpiero Gravante; Muhammad Elmussareh
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

6.  Preliminary experience with radical cystectomy and w-ileal pouch for muscle invasive transitional cell bladder carcinoma.

Authors:  Si Shu'aibu; Hu Liman; Ic Akpayak; Cg Ofoha; Vm Ramyil; Nk Dakum
Journal:  J West Afr Coll Surg       Date:  2012-01

7.  Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder.

Authors:  Michael S Cookson; Sam S Chang; Christine Lihou; Thomas Li; Samira Q Harper; Zhihui Lang; Ronald F Tutrone
Journal:  Ther Adv Urol       Date:  2014-10

8.  Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer.

Authors:  Tatsuo Gondo; Yoshio Ohno; Jun Nakashima; Takeshi Hashimoto; Issei Takizawa; Ayako Tanaka; Kenji Shimodaira; Naoya Satake; Hisashi Takeuchi; Yoshihiro Nakagami; Makoto Ohori; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2013-12-11       Impact factor: 3.402

Review 9.  Diagnosis and management of intradiverticular bladder tumours.

Authors:  Nicholas Faure Walker; Christine Gan; Jonathon Olsburgh; Muhammad Shamim Khan
Journal:  Nat Rev Urol       Date:  2014-06-17       Impact factor: 14.432

10.  The feasibility of radical cystectomy in elderly patients.

Authors:  Sacit Nuri Görgel; Ertuğrul Şefik; Uğur Balcı; Kutan Özer; Cengiz Girgin; Çetin Dinçel
Journal:  Turk J Urol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.